Ukrainian President Volodymyr Zelenskyy has revealed that the United States asked for the first time whether Kyiv would be willing to cede land to Moscow in exchange for fast-tracking Ukraine’s bid to join the North Atlantic Treaty Organization. The disclosure emerged as intensifying aerial attacks continued to exact a heavy toll on civilians on both […]
CoreWeave Inc. reported better-than-expected quarterly revenue and raised its full-year 2026 guidance, offering a reassuring signal that underlying demand for artificial intelligence infrastructure remains robust despite mounting concerns over a broader market slowdown. The announcement, delivered on Tuesday, helped drive the company’s stock higher in extended trading, providing a temporary reprieve during a challenging period […]
Whether developed by OpenAI, Anthropic, or built on top of various open-source alternatives, current artificial intelligence models share a fundamental and critical limitation: they do not natively learn from their own mistakes without further training and human intervention. For businesses attempting to adapt these general-purpose foundation models for specialized and highly regulated fields—such as law, […]
BEIJING — The sweeping victory by Democrats in this week’s midterm elections introduces a fresh layer of unpredictability into Washington’s relationship with Beijing, heightening potential risks for U.S.-China tensions surrounding Taiwan while hardening the ongoing technological competition between the two superpowers, according to political and economic analysts. The Democratic Party captured majorities in both the […]
Whether developed by industry giants like OpenAI and Anthropic or built upon open-source alternatives, current foundational artificial intelligence models share a fundamental and critical limitation: they do not learn from their own mistakes without further training and human intervention. For businesses attempting to adapt these general-purpose models for specialized and high-stakes fields such as law, […]
Eli Lilly reported third-quarter earnings and revenue on Thursday that easily surpassed Wall Street’s consensus expectations, driven by surging international and domestic demand for its blockbuster weight-loss medication Zepbound and its leading-edge diabetes treatment Mounjaro. Reflecting this sustained commercial momentum, the pharmaceutical giant dramatically increased its full-year financial outlook for revenue, even as it navigates […]